ISCO - International Stem Cell Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
8,858
11,089
7,456
7,165
Cost of Revenue
3,331
4,069
2,122
1,944
Gross Profit
5,527
7,020
5,334
5,221
Operating Expenses
Research Development
1,518
2,396
2,658
2,856
Selling General and Administrative
8,513
8,098
7,618
7,216
Total Operating Expenses
10,031
10,494
10,276
10,072
Operating Income or Loss
-4,504
-3,474
-4,942
-4,851
Interest Expense
77
48
59
6
Total Other Income/Expenses Net
2,001
1,391
-1,068
4,706
Income Before Tax
-2,580
-2,131
-6,069
-1,079
Income Tax Expense
-
0
0
0
Income from Continuing Operations
-2,580
-2,131
-6,069
-1,079
Net Income
-2,580
-2,131
-6,069
-1,079
Net Income available to common shareholders
-2,580
-2,131
-6,069
-1,079
Reported EPS
Basic
-
-0.33
-1.46
-0.34
Diluted
-
-0.33
-1.46
-0.34
Weighted average shares outstanding
Basic
-
6,388
4,158
3,190
Diluted
-
6,388
4,158
3,190
EBITDA
-
-1,775
-5,684
-742